BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY) - Roche Holding (OTC:RHHBY)
BALA CYNWYD, Pa., Oct. 16, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.
How this was made

The 30-second read
Why it matters
While the news is factual, its immediate impact appears limited; longer-term effects depend on investigation outcomes.
Market read
The investigation news has moderate relevance for biotech stocks, with limited broader market impact.
What to watch
The investigations' scope and potential outcomes are uncertain; some may turn out to be benign or even beneficial in the long term.
Background
The news pertains to investigations involving multiple biotech and technology companies, which may influence investor sentiment.
Ticker impact
Moderate relevance due to association with biotech sector and ongoing investigations.
Minor short-term price fluctuation within ±2%.
The news is factual and specific; however, lack of detailed investigation scope limits impact certainty.
Market effects
Potential short-term volatility in biotech and life sciences sectors due to investigation news.
Limited regional impact; primarily affecting US-listed biotech stocks.
Minimal global market influence; sector-specific.
Counterpoint
Investors may view investigations as potential catalysts for future positive developments, such as legal resolutions or strategic pivots.
Key entities
- Biotech Company89bio, Inc.
A biotech firm involved in the investigations.
- Biotech CompanyBarinthus Biotherapeutics plc
The primary entity under investigation.
- Technology CompanyVerint Systems Inc.
Mentioned with no direct link to investigations.
- Software CompanyDayforce, Inc.
Mentioned in the context of the investigations.
- Pharmaceutical CompanyRoche Holding
Mentioned but not directly involved in investigations.

